The controlling shareholder of Obio Technology (688238.SH) proposed that the company repurchase shares worth 50 million to 100 million yuan.
"Wah Yuen Biotechnology (688238.SH) announced that the company received a notice from the controlling shareholder on January 23, 2025..."
Obio Technology (688238.SH) announced that on January 23, 2025, the company received a letter from Pan Odong, the controlling shareholder, actual controller, chairman, and general manager of the company, proposing the repurchase of company shares by Obio Technology Technology (Shanghai) Co., Ltd. Pan Odong proposed that the company repurchase some of its issued RMB ordinary shares (A shares) through the Shanghai Stock Exchange trading system via centralized competitive trading. The repurchased shares will be used at a suitable time in the future for equity incentives or employee stock ownership plans, as well as for maintaining the company's value and shareholder interests. The total amount of this repurchase is not less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive).
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


